Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Multiple Sclerosis and Amyotrophic Lateral Sclerosis: Finding and then Losing an Association.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States.
Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis.
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.
The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and Interpretation.
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
The effect of intravenous immunoglobulin on neuromyelitis optica.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Hyperconnectivity is a Fundamental Response to Neurological Disruption.
Interferon Beta and Glatiramer Acetate Therapy.
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.
The long-term cost-effectiveness of the use of Functional Electrical Stimulation for the correction of dropped foot due to upper motor neuron lesion.
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.

Pages